Krebs Biochemicals (India) Investor Sentiment

KREBSBIO   104.14  8.79  7.78%   
Under 62% of Krebs Biochemicals' investor base is looking to short. The analysis of overall sentiment of trading Krebs Biochemicals and stock suggests that many investors are alarmed at this time. Krebs Biochemicals' investing sentiment shows overall attitude of investors towards Krebs Biochemicals and.
  
over six months ago at news.google.com         
Citurgia Biochemicals reports standalone net loss of Rs 0.13 crore in the March 2024 quarter - Busin...
Google News at Macroaxis
over six months ago at news.google.com         
Krebs Biochem Standalone March 2024 Net Sales at Rs 11.97 crore, up 4.47 percent Y-o-Y - Moneycontro...
Google News at Macroaxis
over six months ago at news.google.com         
Rushil Decor Ltd leads losers in B group - Business Standard
Google News at Macroaxis
over six months ago at news.google.com         
Krebs Biochemicals Industries Ltd Share Price Today Krebs Biochemicals Industries Ltd Stock Price Li...
Google News at Macroaxis
over six months ago at news.google.com         
What Percentage Of Krebs Biochemicals Industries Limited Shares Do Insiders Own - Yahoo Movies UK
Google News at Macroaxis
over six months ago at news.google.com         
Krebs Biochemicals Industries reports standalone net loss of Rs 8.14 crore in the June 2022 quarter ...
Google News at Macroaxis
over six months ago at news.google.com         
Krebs Biochemicals Industries reports standalone net loss of Rs 11.31 crore in the March 2022 quarte...
Google News at Macroaxis
over six months ago at news.google.com         
Krebs Biochemicals Industries reports standalone net loss of Rs 4.98 crore in the December 2023 quar...
Google News at Macroaxis
over six months ago at news.google.com         
Citurgia Biochemicals reports standalone net loss of Rs 0.11 crore in the December 2023 quarter - Bu...
Google News at Macroaxis
over six months ago at news.google.com         
Krebs Biochemicals Industr Q3 FY24 Results Live Loss Falls by 10. percent YoY Mint - Mint
Google News at Macroaxis
over six months ago at news.google.com         
Krebs Biochemicals Industries reports standalone net loss of Rs 4.98 crore in the December 2023 quar...
Google News at Macroaxis
over six months ago at news.google.com         
Krebs Biochemicals Industries to hold board meeting - Trade Brains
Google News at Macroaxis
over a year ago at news.google.com         
Krebs Biochemicals Industries Second Quarter 2024 Earnings 1.66 loss per share - Simply Wall St
Google News at Macroaxis
over a year ago at news.google.com         
Circuit Limit Change 7 , 70 percent - CNBCTV18
Google News at Macroaxis
over a year ago at news.google.com         
RailTel Corporation of India Limiteds Stock On An Uptrend Could Fundamentals Be Driving The Momentum...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Krebs Biochemicals that are available to investors today. That information is available publicly through Krebs media outlets and privately through word of mouth or via Krebs internal channels. However, regardless of the origin, that massive amount of Krebs data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Krebs Biochemicals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Krebs Biochemicals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Krebs Biochemicals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Krebs Biochemicals alpha.

Krebs Biochemicals Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Krebs Biochem Standalone September 2024 Net Sales at Rs 12.86 crore, down 13.67 percent Y-o-Y - Moneycontrol
11/12/2024

Complementary Tools for Krebs Stock analysis

When running Krebs Biochemicals' price analysis, check to measure Krebs Biochemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krebs Biochemicals is operating at the current time. Most of Krebs Biochemicals' value examination focuses on studying past and present price action to predict the probability of Krebs Biochemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krebs Biochemicals' price. Additionally, you may evaluate how the addition of Krebs Biochemicals to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Valuation
Check real value of public entities based on technical and fundamental data